AMN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
673.2M
-51.2%
1.4B
+84.2%
748.2M
+17.9%
634.5M
-3.6%
658.2M
Cost of Revenue
467.4M
-53.7%
1.0B
+82.5%
553.1M
+22.9%
450.1M
-2.5%
461.8M
Gross Profit
205.9M
-44.2%
368.8M
+89.0%
195.1M
+5.8%
184.4M
-6.1%
196.4M
Operating Expenses
179.0M
-28.9%
251.7M
+11.3%
226.1M
+65.3%
136.8M
-57.3%
320.1M
R&D
0
0
0
0
0
SG&A
147.4M
-32.5%
218.4M
+43.6%
152.1M
+9.8%
138.6M
-10.3%
154.6M
Operating Income
26.9M
-77.0%
117.2M
+477.7%
-31020000
-165.1%
47.6M
+138.5%
-123715000
EBITDA
61.0M
-60.1%
152.8M
+2361.0%
6.2M
-92.9%
87.2M
+98.5%
43.9M
Net Income
21.2M
-66.0%
62.2M
+907.8%
-7696000
-126.3%
29.3M
+125.2%
-116202000
EPS (Basic)
$0.54
-66.3%
$1.60
+900.0%
$-0.20
-126.3%
$0.76
+125.2%
$-3.02
EPS (Diluted)
$0.53
-66.7%
$1.59
+895.0%
$-0.20
-126.3%
$0.76
+125.2%
$-3.02
Shares (Diluted)
39.7M
+1.6%
39.1M
+1.2%
38.7M
-0.1%
38.7M
+0.7%
38.4M
AMN Healthcare Services (AMN) โ€” Financials